Treatment Action Group

Activists call on countries and donors to immediately scale up use of life-saving TB LAM test

Provocative distribution of yellow lemonade in urine collection cups calls attention to need for this simple, urine-based test.

Read More →

Strengthening TB research in NIAID's TB Strategic Plan

July 17, 2018 – Treatment Action Group (TAG) submitted comments to the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. National Institutes of Health (NIH) in response to a public request for information (RFI) to inform NIAID's TB Strategic Plan on supporting TB research and development (R&D).

Read More →

Webinar: Implementing a bedaquiline-based, injectable-free regimen for drug-resistant TB

Treatment Action Group (TAG), the Global TB Community Advisory Board (TB CAB) and DR-TB STAT will host a webinar on 1 August 2018 at 10 am New York / 4pm South Africa / 5pm Kenya on implementing a bedaquiline-based, injectable-free regimen for drug-resistant TB.

Read More →

TB research briefing for UN Missions - videos now available online

A TB research briefing for UN Missions in New York City on 4 June 2018 provided an opportunity for discussion on the importance of investing in the full spectrum of TB research, and adopting principles to guide research to ensure efficiency and equitable access. The event featured Dr. Soumya Swaminathan, Deputy Director-General for Programs, World Health Organization, as the keynote speaker and then had three panels.

Read More →

Treatment Action Group welcomes price reductions for TB medicines

Countries and donors must do more to ensure all people with TB have access; further price reductions for newer medicines required.

Read More →

New tools to support TB and HLM advocacy: TB R&D brief and Pediatric TB brief

Treatment Action Group (TAG), along with partners, announced the release of two additional tools and resources to support advancing TB advocacy with national governments, in the context of the UN High-Level Meeting on TB taking place in September this year.

Read More →

TAGline Spring 2018: Bend the curves

Treatment Action Group releases the spring issue of TAGline, Bend the curves: Activism and the elimination of HIV, HCV, and TB.

Read More →

New guide to shorter regimen for treating drug-resistant TB

DR-TB STAT + TAG brief: Is Shorter Better? Understanding the Shorter Regimen For Treating Drug-Resistant Tuberculosis

Read More →

Webinar: It’s Time to Deliver: Including Pregnant and Lactating Women in Clinical Research

The U.S. Division of AIDS (DAIDS) and its prevention and International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) networks have a long history of including pregnant and lactating women in clinical trials and of developing research agendas that target long standing and new knowledge gaps necessary to meet the needs of this neglected population.

Read More →

New guide: Your rights and TB care

An innovative and important new TB resource – Know Your Rights: Tuberculosis Prevention, Diagnosis, and Treatment Guide.

Read More →

Page 1 of 11 · Total posts: 10

1 2 Last→